持続血糖モニタリングの世界市場レポート 2025年

持続血糖モニタリングの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.7％で231億5,000万米ドルに成長します。予測期間の成長は、高齢化人口の増加、在宅ヘルスケアの増加、テレヘルスの拡大、医療費の増加、可処分所得の増加に起因します。予測期間の主な動向には、ウェアラブル統合、人工知能と機械学習、高度なセンサーと精度、パートナーシップとコラボレーションなどがあります。

糖尿病の有病率の上昇は、今後の持続血糖モニタリング市場の成長を促進すると予想されます。糖尿病は、体内の血糖値の変動を特徴とする健康状態です。血糖モニタリング機器は、糖尿病患者の状態をより明確に全体的に把握するための動向やパターンの特定に役立ちます。例えば、国際糖尿病連合（IDF）は最近、20歳から79歳の成人の約5億3,700万人が現在世界中で糖尿病とともに生活していると報告しました。この数字は、以前の推定値から大幅に増加しており、糖尿病有病率の厄介な動向を浮き彫りにしています。IDFは、この数字は2030年までに6億4,300万人に達し、さらに2045年までに7億8,300万人に増加すると予測しています。したがって、糖尿病有病率の増加は、今後数年間の持続血糖モニタリング市場の成長を促進します。

病院の急増は、持続血糖モニタリング市場の拡大に貢献する見通しです。医療や外科治療を専門とする病院では、特に糖尿病患者やグルコース関連合併症のリスクを抱える患者の血糖値を正確かつ継続的にモニタリングするために、持続血糖モニタリングが不可欠であると考えられています。2023年9月のDiscovery Therapyによると、米国には2021年に約6,090の病院があったが、世界全体では約165,000の病院がありました。また、2023年5月の米国病院協会の報告によると、2022年のアメリカの病院数は6,129でした。世界の病院数の増加は、持続血糖モニタリング市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界持続血糖モニタリング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の持続血糖モニタリング市場：成長率分析
• 世界の持続血糖モニタリング市場の実績：規模と成長, 2019-2024
• 世界の持続血糖モニタリング市場の予測：規模と成長, 2024-2029, 2034F
• 世界持続血糖モニタリング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の持続血糖モニタリング市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• インスリンポンプ
• センサー
• 送信機
• 受信機
• 世界の持続血糖モニタリング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 1型糖尿病患者
• 2型糖尿病患者
• 妊娠糖尿病
• 重症患者
• 世界の持続血糖モニタリング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア診断
• その他のエンドユーザー
• 世界の持続血糖モニタリング市場インスリンポンプの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• チューブレスインスリンポンプ
• チューブ型インスリンポンプ
• パッチポンプ
• 世界の持続血糖モニタリング市場、センサーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 持続血糖モニタリングセンサー
• フラッシュ血糖モニタリングセンサー
• 埋め込み型センサー
• 世界の持続血糖モニタリング市場、送信機の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 統合型トランスミッター
• 無線送信機
• Bluetooth対応トランスミッター
• 世界の持続血糖モニタリング市場、受信機のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スタンドアロン受信機
• スマートフォンアプリ
• 統合デバイス

第7章 地域別・国別分析

• 世界の持続血糖モニタリング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の持続血糖モニタリング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 持続血糖モニタリング市場：競合情勢
• 持続血糖モニタリング市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Lifescan Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • GlySens Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Arkray
• Senseonics Holdings Inc.
• Glysure Limited
• Nemaura Medical Inc.
• Tandem Diabetes Care Inc.
• AgaMatrix Inc.
• B. Braun Melsungen AG
• Ypsomed Holding AG
• Terumo Corporation
• Orsense Ltd.
• Dexcom Inc.
• A. Menarini Diagnostics
• Johnson & Johnson Services Inc.
• Ascensia Diabetes Care Holdings AG
• Insulet Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 持続血糖モニタリング市場2029：新たな機会を提供する国
• 持続血糖モニタリング市場2029：新たな機会を提供するセグメント
• 持続血糖モニタリング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Continuous Blood Glucose Monitoring (CGM) involves using a sensor under the skin to constantly track glucose levels. It provides real-time data and alerts for high or low glucose, assisting people with diabetes in managing their blood sugar levels more effectively.

The main components in continuous blood glucose monitoring devices include insulin pumps, sensors, transmitters, and receivers. Insulin pumps are compact, computerized devices that are programmed to administer pre-determined doses of insulin at specific intervals. These devices are particularly utilized by individuals with type 1 diabetes, type 2 diabetes, gestational diabetes, and critical care patients. The end-users for continuous blood glucose monitoring devices include hospitals, homecare diagnostics, and various other settings.

The continuous blood glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous blood glucose monitoring market size has grown strongly in recent years. It will grow from $13.57 billion in 2024 to $14.87 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increase in diabetes prevalence, regulatory compliance, demand for remote monitoring, emerging markets, rise in healthcare spending.

The continuous blood glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $23.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to growing aging population, rising home healthcare, telehealth expansion, rise in healthcare expenditure, rise in disposable income. Major trends in the forecast period include wearable integration, artificial intelligence and machine learning, advanced sensors and accuracy, partnerships and collaboration.

The rising prevalence of diabetes is expected to drive the growth of the continuous blood glucose monitoring market in the future. Diabetes is a health condition characterized by fluctuating blood glucose levels in the body. Blood glucose monitoring devices help identify trends and patterns that provide a clearer overall picture of a diabetic individual's condition. For example, the International Diabetes Federation (IDF) recently reported that approximately 537 million adults aged 20 to 79 are currently living with diabetes worldwide. This figure represents a significant increase from earlier estimates and underscores a troubling trend in diabetes prevalence. The IDF anticipates that this number will reach 643 million by 2030 and further rise to 783 million by 2045. Therefore, the increasing prevalence of diabetes is propelling the growth of the continuous blood glucose monitoring market in the coming years.

The proliferation of hospitals is poised to contribute to the expansion of the continuous blood glucose monitoring market. Hospitals, dedicated to providing medical or surgical treatment, find continuous blood glucose monitoring crucial for precise and ongoing monitoring of blood glucose levels, particularly for patients with diabetes or those at risk of glucose-related complications. According to Discovery Therapy in September 2023, the US had around 6,090 hospitals in 2021, while globally, there were approximately 165,000 hospitals. Additionally, the American Hospital Association reported in May 2023 that there were 6,129 hospitals in America in 2022. The increased number of hospitals globally is expected to drive the growth of the continuous blood glucose monitoring market.

Technological advancements have become a significant trend gaining traction in the continuous blood glucose monitoring market. Major companies in this sector are concentrating on developing cutting-edge technological solutions to strengthen their market position. For example, in 2022, Philips broadened its range of home care solutions for patients with chronic obstructive pulmonary disease (COPD) by launching the BiPAP A40 EFL, a non-invasive ventilator designed to improve patient comfort and decrease hospital readmissions. This ventilator utilizes Philips' proprietary ExpiraFlow technology, which enables healthcare professionals to automatically detect expiratory flow limitation (EFL) in COPD patients and deliver personalized therapy.

Major companies in the diabetes care devices market are innovating new products, such as the Medtronic Extended Infusion Set, to enhance their profitability. The Medtronic Extended Infusion Set is a tubing system designed to deliver insulin from the pump to the body, with a wear duration of up to 7 days. For instance, in 2023, Medtronic Plc expanded the availability of its Extended Infusion Set, which was initially launched in select European countries, to include additional markets throughout Europe and the Asia-Pacific region. This innovative device continues to simplify the insulin delivery process for diabetes patients, featuring a user-friendly all-in-one serter that makes set changes more efficient. The Extended Infusion Set allows for extended wear of up to 7 days, thanks to its advanced technology and materials, significantly exceeding the standard wear duration of typical infusion sets.

In a strategic move in May 2023, Medtronic PLC., an Ireland-based medical device company, acquired EOFlow for an undisclosed amount. This acquisition is geared towards strengthening Medtronic's diabetes product portfolio and expanding its capacity to offer comprehensive support to a larger global community managing diabetes, all within a unified Medtronic ecosystem. EOFlow Co. Ltd., based in South Korea, is recognized for manufacturing the insulin patch pump EOPatch. This strategic acquisition aligns with Medtronic's commitment to continuous growth and innovation in the diabetes care devices market.

Major companies operating in the continous blood glucose monitoring market include F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Goldsite Diagnostics Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Echo Therapeutics Inc., Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Texas Instruments Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality, Nemotecnia S.A.

North America was the largest region in the continuous blood glucose monitoring market in 2023. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the continuous blood glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Blood Glucose Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous blood glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous blood glucose monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous blood glucose monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Insulin Pumps; Sensors; Transmitters; Receivers
• 2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients
• 3) By End User: Hospitals; Homecare Diagnostics; Other End Users
• Subsegments:
• 1) By Insulin Pumps: Tubeless Insulin Pumps; Tubed Insulin Pumps; Patch Pumps
• 2) By Sensors: Continuous Glucose Monitoring Sensors; Flash Glucose Monitoring Sensors; Implantable Sensors
• 3) By Transmitters: Integrated Transmitters; Wireless Transmitters; Bluetooth-enabled Transmitters
• 4) By Receivers: Standalone Receivers; Smartphone Apps; Integrated Devices
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Lifescan Inc.; Medtronic plc.; Abbott Laboratories; GlySens Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Continuous Blood Glucose Monitoring Market Characteristics

3. Continuous Blood Glucose Monitoring Market Trends And Strategies

4. Continuous Blood Glucose Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Continuous Blood Glucose Monitoring Growth Analysis And Strategic Analysis Framework

• 5.1. Global Continuous Blood Glucose Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Continuous Blood Glucose Monitoring Market Growth Rate Analysis
• 5.4. Global Continuous Blood Glucose Monitoring Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Continuous Blood Glucose Monitoring Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Continuous Blood Glucose Monitoring Total Addressable Market (TAM)

6. Continuous Blood Glucose Monitoring Market Segmentation

• 6.1. Global Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin Pumps
• Sensors
• Transmitters
• Receivers
• 6.2. Global Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Type 1 Diabetic Patients
• Type 2 Diabetic Patients
• Gestational Diabetes
• Critical Care Patients
• 6.3. Global Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare Diagnostics
• Other End Users
• 6.4. Global Continuous Blood Glucose Monitoring Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tubeless Insulin Pumps
• Tubed Insulin Pumps
• Patch Pumps
• 6.5. Global Continuous Blood Glucose Monitoring Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Continuous Glucose Monitoring Sensors
• Flash Glucose Monitoring Sensors
• Implantable Sensors
• 6.6. Global Continuous Blood Glucose Monitoring Market, Sub-Segmentation Of Transmitters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Integrated Transmitters
• Wireless Transmitters
• Bluetooth-enabled Transmitters
• 6.7. Global Continuous Blood Glucose Monitoring Market, Sub-Segmentation Of Receivers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standalone Receivers
• Smartphone Apps
• Integrated Devices

7. Continuous Blood Glucose Monitoring Market Regional And Country Analysis

• 7.1. Global Continuous Blood Glucose Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Continuous Blood Glucose Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Continuous Blood Glucose Monitoring Market

• 8.1. Asia-Pacific Continuous Blood Glucose Monitoring Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Continuous Blood Glucose Monitoring Market

• 9.1. China Continuous Blood Glucose Monitoring Market Overview
• 9.2. China Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Continuous Blood Glucose Monitoring Market

• 10.1. India Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Continuous Blood Glucose Monitoring Market

• 11.1. Japan Continuous Blood Glucose Monitoring Market Overview
• 11.2. Japan Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Continuous Blood Glucose Monitoring Market

• 12.1. Australia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Continuous Blood Glucose Monitoring Market

• 13.1. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Continuous Blood Glucose Monitoring Market

• 14.1. South Korea Continuous Blood Glucose Monitoring Market Overview
• 14.2. South Korea Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Continuous Blood Glucose Monitoring Market

• 15.1. Western Europe Continuous Blood Glucose Monitoring Market Overview
• 15.2. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Continuous Blood Glucose Monitoring Market

• 16.1. UK Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Continuous Blood Glucose Monitoring Market

• 17.1. Germany Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Continuous Blood Glucose Monitoring Market

• 18.1. France Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Continuous Blood Glucose Monitoring Market

• 19.1. Italy Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Continuous Blood Glucose Monitoring Market

• 20.1. Spain Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Continuous Blood Glucose Monitoring Market

• 21.1. Eastern Europe Continuous Blood Glucose Monitoring Market Overview
• 21.2. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Continuous Blood Glucose Monitoring Market

• 22.1. Russia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Continuous Blood Glucose Monitoring Market

• 23.1. North America Continuous Blood Glucose Monitoring Market Overview
• 23.2. North America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Continuous Blood Glucose Monitoring Market

• 24.1. USA Continuous Blood Glucose Monitoring Market Overview
• 24.2. USA Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Continuous Blood Glucose Monitoring Market

• 25.1. Canada Continuous Blood Glucose Monitoring Market Overview
• 25.2. Canada Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Continuous Blood Glucose Monitoring Market

• 26.1. South America Continuous Blood Glucose Monitoring Market Overview
• 26.2. South America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Continuous Blood Glucose Monitoring Market

• 27.1. Brazil Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Continuous Blood Glucose Monitoring Market

• 28.1. Middle East Continuous Blood Glucose Monitoring Market Overview
• 28.2. Middle East Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Continuous Blood Glucose Monitoring Market

• 29.1. Africa Continuous Blood Glucose Monitoring Market Overview
• 29.2. Africa Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Continuous Blood Glucose Monitoring Market Competitive Landscape And Company Profiles

• 30.1. Continuous Blood Glucose Monitoring Market Competitive Landscape
• 30.2. Continuous Blood Glucose Monitoring Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Lifescan Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlySens Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Continuous Blood Glucose Monitoring Market Other Major And Innovative Companies

• 31.1. Arkray
• 31.2. Senseonics Holdings Inc.
• 31.3. Glysure Limited
• 31.4. Nemaura Medical Inc.
• 31.5. Tandem Diabetes Care Inc.
• 31.6. AgaMatrix Inc.
• 31.7. B. Braun Melsungen AG
• 31.8. Ypsomed Holding AG
• 31.9. Terumo Corporation
• 31.10. Orsense Ltd.
• 31.11. Dexcom Inc.
• 31.12. A. Menarini Diagnostics
• 31.13. Johnson & Johnson Services Inc.
• 31.14. Ascensia Diabetes Care Holdings AG
• 31.15. Insulet Corporation

32. Global Continuous Blood Glucose Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Blood Glucose Monitoring Market

34. Recent Developments In The Continuous Blood Glucose Monitoring Market

35. Continuous Blood Glucose Monitoring Market High Potential Countries, Segments and Strategies

• 35.1 Continuous Blood Glucose Monitoring Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Continuous Blood Glucose Monitoring Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Continuous Blood Glucose Monitoring Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer